JM
JP Morgan Latest Price Targets & Analyst Ratings
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
2201 |
2201
Ironwood Pharmaceuticals
IRWD
$195M
|
EJ
Eric Joseph
| $1.20 | $10.89 |
808%
upside
| Neutral |
24 Jan ‘19
6 years ago |
|
2202 |
2202
Tencent Music
TME
$39.6B
| $25.70 | $16 |
38%
downside
| Overweight |
17 Jan ‘19
6 years ago |
|
|
2203 |
GPMT
2203
Granite Point Mortgage Trust
GPMT
$144M
|
RS
Richard Shane
| $3.04 | $19.50 |
541%
upside
| Neutral |
16 Jan ‘19
6 years ago |
|
2204 |
KREF
2204
KKR Real Estate Finance Trust
KREF
$646M
|
CB
Christopher Brown
| $9.84 | $20.50 |
108%
upside
| Neutral |
16 Jan ‘19
6 years ago |
|
2205 |
2205
Targa Resources
TRGP
$35.5B
| $164.90 | $54 |
67%
downside
| Overweight |
8 Jan ‘19
6 years ago |
|
|
2206 |
2206
MaxLinear
MXL
$1.37B
| $15.78 | $18 |
14%
upside
| Neutral |
4 Jan ‘19
6 years ago |
|
|
2207 |
2207
Coty
COTY
$3.6B
|
JF
John Faucher
| $4.13 | $7 |
69%
upside
| Neutral |
4 Jan ‘19
6 years ago |
|
2208 |
2208
Vornado Realty Trust
VNO
$7.96B
|
AP
Anthony Paolone
| $41.45 | $72 |
74%
upside
| Underweight |
19 Dec ‘18
6 years ago |
|
2209 |
2209
Zimmer Biomet
ZBH
$20.5B
| $103.71 | $114.56 |
10%
upside
| Neutral |
19 Dec ‘18
6 years ago |
|
|
2210 |
2210
Kennedy-Wilson Holdings
KW
$1.25B
| $9.09 | $25 |
175%
upside
| Overweight |
19 Dec ‘18
6 years ago |
|
|
2211 |
2211
Genpact
G
$7.52B
|
JB
John Bridges
| $43.15 | $32 |
26%
downside
| Neutral |
17 Dec ‘18
6 years ago |
|
2212 |
2212
Aramark
ARMK
$10.2B
| $38.79 | $31.77 |
18%
downside
| Overweight |
12 Dec ‘18
6 years ago |
|
|
2213 |
2213
Waters Corp
WAT
$17.9B
|
TP
Tycho Peterson
| $300.11 | $180 |
40%
downside
| Underweight |
12 Dec ‘18
6 years ago |
|
2214 |
2214
Tyson Foods
TSN
$19.9B
| $55.98 | $60 |
7%
upside
| Neutral |
11 Dec ‘18
6 years ago |
|
|
2215 |
2215
Darling Ingredients
DAR
$5.06B
|
TP
Thomas Plamer
| $31.98 | $25 |
22%
downside
| Overweight |
19 Nov ‘18
6 years ago |
|
2216 |
2216
Kellanova
K
$27.6B
|
KG
Kenneth Goldman
| $79.50 | $61.97 |
22%
downside
| Neutral |
14 Nov ‘18
6 years ago |
|
2217 |
2217
Sangamo Therapeutics
SGMO
$160M
|
EJ
Eric Joseph
| $0.5305 | $11 |
1,974%
upside
| Neutral |
14 Nov ‘18
6 years ago |
|
2218 |
2218
Allogene Therapeutics
ALLO
$253M
| $1.14 | $29 |
2,444%
upside
| Neutral |
5 Nov ‘18
6 years ago |
|
|
2219 |
2219
NiSource
NI
$19.3B
|
CT
Christopher Turnure
| $40.91 | $28 |
32%
downside
| Overweight |
2 Nov ‘18
6 years ago |
|
2220 |
2220
Puma Biotechnology
PBYI
$229M
|
CK
Cory Kasimov
| $4.54 | $23 |
407%
upside
| Underweight |
2 Nov ‘18
6 years ago |
|
2221 |
2221
Carlyle Group
CG
$24.4B
|
KW
Ken Worthington
| $67.46 | $28 |
58%
downside
| Overweight |
2 Nov ‘18
6 years ago |
|
2222 |
2222
Repligen
RGEN
$6.76B
|
TP
Tycho Peterson
| $120.24 | $70 |
42%
downside
| Overweight |
2 Nov ‘18
6 years ago |
|
2223 |
2223
Pacira BioSciences
PCRX
$1.21B
|
CS
Chris Schott
| $26.84 | $50 |
86%
upside
| Neutral |
2 Nov ‘18
6 years ago |
|
2224 |
2224
Griffon
GFF
$3.73B
| $80.07 | $11 |
86%
downside
| Underweight |
30 Oct ‘18
6 years ago |
|
|
2225 |
2225
Guardant Health
GH
$7.13B
|
TP
Tycho Peterson
| $57.16 | $42 |
27%
downside
| Overweight |
29 Oct ‘18
6 years ago |
|